Symptoms include severe abdominal pain that may spread to your back, nausea, and vomiting
Direct injectable NAD+ has more limited human RCT data but rapid systemic availability
The Bottom Line (Plain English) Weeks 12: appetite changes, little scale movement Weeks 36: weight loss often begins Months 36: meaningful, sustained loss for many Semaglutide: slower start, steady progress Tirzepatide: faster early loss for some, same long-term rules apply GLP-1 rewards patience not urgency
The best choice depends on how your body responds and what feels most comfortable for you
Hong Kongs Prenetics along with a certain David Beckham have founded a brand, IM8 Health, to market the supplement
Investor Elad Gil led the round, with participation from venture capital fund Khosla Ventures and prominent real estate developers Lennar and Tishman Speyer